Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Atherectomy devices Market: By Technology By Indication, By End User and By Region Forecast 2020-2031
Atherectomy devices Market: By Technology By Indication, By End User and By Region Forecast 2020-2031
Atherectomy Devices Market size was valued at US$ 184.8 million in 2024 and is expected to reach US$ 292.8 million by 2031, growing at a significant CAGR of 6.80% from 2025-2031. market is expected to have a significant growth rate over the forecast period owing to the increase in prevalence of heart diseases around the world. According to the World Health Organization, due to cardiovascular diseases, 17.7 Mn people died in the year 2015, and 7.4 Mn were due to coronary heart diseases. The market is consolidated due to the presence of strong players. Companies are using strategies such as acquisitions and collaborations to increase their market share. Atherectomy is a minimally invasive surgery to remove the atherosclerotic plaque from arteries.
Atherosclerotic plaque is either localized in coronary or peripheral atrial vasculature and many have different characteristics based on the texture. Atherosclerotic devices are used for atherectomy. Various atherectomy devices are designed based on their mechanisms such as cut, saving, sand or vaporizing the plaques, and have different indications. Atherectomy is an alternative to angioscopy and it is also used for coronary artery disease.
Study Period
2025-2031Base Year
2024CAGR
6.8%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The primary driver for the global atherectomy devices market is the significant rise in peripheral vascular diseases around the globe. In addition, the rise in demand for minimally invasive devices such as atherectomy devices which shorten the recovery time and provide effective treatment expected to boost the global market over the forecast period. Furthermore, technological advancements such as the emergence of laser atherectomy and the rise in the aging population who has a high risk of getting atherosclerosis are expected to bolster the market share over the forecast period. However, presence of the alternative treatments is expected to hamper the market growth over the projected period.
North America atherectomy devices market is expected to have a significant growth rate owing to the adaptation of minimally invasive technologies for the treatment of diseases and prevalence of the heart diseases such as coronary artery disease and peripheral artery disease. Europe's market is expected to grow at notable rates owing to the new product launches and public awareness, technological advancements, and adaptation of minimally invasive devices.
In April 2017, Ra Medical Systems launched DABRA atherectomy system in Europe, and the system received a CE mark in October 2016. Asia Pacific market is projecting the lucrative growth opportunity owing to the developing healthcare infrastructure and prevalence of the artery diseases. Furthermore, the rise in aging population and company expansion to emerging countries such as India and China are expected to boost the market growth in the Asia Pacific region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 184.8 million |
|
Market Size in 2031 |
US$ 292.8 million |
|
Market CAGR |
6.8% |
|
By Indication |
|
|
By Technology |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Atherectomy Devices Market size was valued at US$ 184.8 million in 2024 and is expected to reach US$ 292.8 million by 2031, growing at a significant CAGR of 6.80% from 2025-2031.
Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (Cardinal Health, Inc.) (U.S.), R. Bard, Inc. (U.S.), Koninklijke Philips N.V. (Volcano Corporation) (Netherlands), Medtronic Plc (U.S.) .
North America is the fastest-growing region for the market
| 1. Executive Summary |
| 2. Global Atherectomy Devices Market Introduction |
| 2.1.Global Atherectomy Devices Market - Taxonomy |
| 2.2.Global Atherectomy Devices Market - Definitions |
| 2.2.1.Indication |
| 2.2.2.Technology |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Atherectomy Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Atherectomy Devices Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Atherectomy Devices Market By Indication, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Peripheral Artery Disease |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Coronary Artery Disease |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Atherectomy Devices Market By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Orbital Atherectomy |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Rotational Atherectomy |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Orbital Atherectomy |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Directional Atherectomy |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Atherectomy Devices Market By End Users, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Atherectomy Devices Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Atherectomy Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Peripheral Artery Disease |
| 9.1.2.Coronary Artery Disease |
| 9.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Orbital Atherectomy |
| 9.2.2.Rotational Atherectomy |
| 9.2.3.Orbital Atherectomy |
| 9.2.4.Directional Atherectomy |
| 9.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers |
| 9.3.3.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Atherectomy Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Peripheral Artery Disease |
| 10.1.2.Coronary Artery Disease |
| 10.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Orbital Atherectomy |
| 10.2.2.Rotational Atherectomy |
| 10.2.3.Orbital Atherectomy |
| 10.2.4.Directional Atherectomy |
| 10.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers |
| 10.3.3.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Atherectomy Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Peripheral Artery Disease |
| 11.1.2.Coronary Artery Disease |
| 11.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Orbital Atherectomy |
| 11.2.2.Rotational Atherectomy |
| 11.2.3.Orbital Atherectomy |
| 11.2.4.Directional Atherectomy |
| 11.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers |
| 11.3.3.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Atherectomy Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Peripheral Artery Disease |
| 12.1.2.Coronary Artery Disease |
| 12.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Orbital Atherectomy |
| 12.2.2.Rotational Atherectomy |
| 12.2.3.Orbital Atherectomy |
| 12.2.4.Directional Atherectomy |
| 12.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers |
| 12.3.3.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Atherectomy Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Indication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Peripheral Artery Disease |
| 13.1.2.Coronary Artery Disease |
| 13.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Orbital Atherectomy |
| 13.2.2.Rotational Atherectomy |
| 13.2.3.Orbital Atherectomy |
| 13.2.4.Directional Atherectomy |
| 13.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers |
| 13.3.3.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Boston Scientific Corporation (U.S.) |
| 14.2.2.R. Bard, Inc. (U.S.) |
| 14.2.3.Abbott Laboratories (U.S.) |
| 14.2.4.Koninklijke Philips N.V. (Volcano Corporation) (Netherlands) |
| 14.2.5.Medtronic Plc (U.S.) |
| 14.2.6.Cordis Corporation (Cardinal Health, Inc.) (U.S.) |
| 14.2.7.Jude Medical, Inc. (U.S.) |
| 14.2.8.Terumo Medical Corporation (TERUMO CORPORATION) (Japan) |
| 14.2.9.Spectranetics International BV (Netherlands) |
| 14.2.10.Avinger, Inc. (U.S.) |
| 14.2.11.Ra Medical Systems Inc. (U.S.) |
| 14.2.12.Cardiovascular Systems, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.